Three Methods Evaluated for Malaria Detection
By LabMedica International staff writers Posted on 23 May 2017 |

Image: Malaria parasites in a red blood cell (Photo courtesy of SPL).
Malaria is a debilitating disease with high morbidity and mortality in Africa, commonly caused by different species of the genus Plasmodium in humans. Misdiagnosis is a major challenge in endemic areas because of other disease complications and technical expertise of the medical laboratory staff.
The microscopic examination of Giemsa-stained thick and thin blood films has been used for the laboratory diagnosis of malaria for many years. The limitation of microscopy led to the development of reliable, easy-to-perform rapid diagnostic tests (RDTs) to detect the presence of malaria parasites at levels of accuracy compared to skilled microscopists.
Scientists at the Federal University Ndufu-Alike Ikwo and their colleagues used simple random sampling of a populations comprised of individuals who had shown clinical signs of malaria and in whom test for malaria parasite have been requested for by clinicians. The subject population included persons of different age groups such as children, adults and pregnant women. Peripheral blood samples were collected by finger prick and by venipuncture.
The study participants were screened for malaria parasites using Giemsa-stained malaria microscopy, three RDT kits, among the specimens collected, a total of 50 were randomly selected for nested polymerase chain reaction (PCR). Three different commercially available RDT kits for malaria parasites having different sensitivity and specificity were used to detect malaria parasites in the blood samples. These were; Carestart, SD Bioline PF and SD Bioline PF/PV. Molecular analysis was performed using a PCR technique based on amplification of 18s rRNA genes.
The team reported that malaria parasite was detected in 109/420 (25.95%) of the subjects by microscopy and all the species detected by microscopy were observed to be P. falciparum. Among the subjects studied, 96 (22.9%), 64 (15.2%) and 230 (54.8%) were positive by Carestart, SD Bioline PF and SD Bioline PF/PV respectively. Among the specimens that were subjected to molecular analysis, 16 (32.0%) were positive while 34 (68.0%) were negative for Plasmodium genes. Plasmodium falciparum was observed in all positive cases, P. malariae was present in 5/16 cases while P. ovale was present in 1/16 subject. Both of the latter species were present as co-infection with P. falciparum in all the subjects they were found.
The authors concluded that microscopy is still a good method for the diagnosis of malaria and having a good measure of agreement with PCR. Hence it is recommended that the laboratory diagnosis of malaria be performed using both microscopy and RDT of high sensitivity and specificity. The combination of these methods will ensure that laboratory reports on malaria diagnosis are of very high accuracy. The study was published on May 6, 2017, in the Malaria Journal.
The microscopic examination of Giemsa-stained thick and thin blood films has been used for the laboratory diagnosis of malaria for many years. The limitation of microscopy led to the development of reliable, easy-to-perform rapid diagnostic tests (RDTs) to detect the presence of malaria parasites at levels of accuracy compared to skilled microscopists.
Scientists at the Federal University Ndufu-Alike Ikwo and their colleagues used simple random sampling of a populations comprised of individuals who had shown clinical signs of malaria and in whom test for malaria parasite have been requested for by clinicians. The subject population included persons of different age groups such as children, adults and pregnant women. Peripheral blood samples were collected by finger prick and by venipuncture.
The study participants were screened for malaria parasites using Giemsa-stained malaria microscopy, three RDT kits, among the specimens collected, a total of 50 were randomly selected for nested polymerase chain reaction (PCR). Three different commercially available RDT kits for malaria parasites having different sensitivity and specificity were used to detect malaria parasites in the blood samples. These were; Carestart, SD Bioline PF and SD Bioline PF/PV. Molecular analysis was performed using a PCR technique based on amplification of 18s rRNA genes.
The team reported that malaria parasite was detected in 109/420 (25.95%) of the subjects by microscopy and all the species detected by microscopy were observed to be P. falciparum. Among the subjects studied, 96 (22.9%), 64 (15.2%) and 230 (54.8%) were positive by Carestart, SD Bioline PF and SD Bioline PF/PV respectively. Among the specimens that were subjected to molecular analysis, 16 (32.0%) were positive while 34 (68.0%) were negative for Plasmodium genes. Plasmodium falciparum was observed in all positive cases, P. malariae was present in 5/16 cases while P. ovale was present in 1/16 subject. Both of the latter species were present as co-infection with P. falciparum in all the subjects they were found.
The authors concluded that microscopy is still a good method for the diagnosis of malaria and having a good measure of agreement with PCR. Hence it is recommended that the laboratory diagnosis of malaria be performed using both microscopy and RDT of high sensitivity and specificity. The combination of these methods will ensure that laboratory reports on malaria diagnosis are of very high accuracy. The study was published on May 6, 2017, in the Malaria Journal.
Latest Microbiology News
- Credit Card-Sized Test Boosts TB Detection in HIV Hotspots
- Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients
- Portable Molecular POC System Rules Out UTIs in Just 35 Minutes
- POC Lateral Flow Test Detects Deadly Fungal Infection Faster Than Existing Techniques
- Rapid Diagnostic Test Slashes Sepsis Mortality by 39%
- Blood Culture Assay Enhances Diagnostic Stewardship Through Targeted Panel Selection
- Real-Time Genome Sequencing Detects Dangerous Superbug Causing Hospital Infections
- Diagnostic Test Accurately Detects Colorectal Cancer by Identifying Microbial Signature in Gut Bacteria
- Rapid Bedside Test Predicts Sepsis with Over 90% Accuracy
- New Blood Test Detects Up to Five Infectious Diseases at POC
- Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
- New Test Diagnoses Bacterial Meningitis Quickly and Accurately
- Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
Channels
Clinical Chemistry
view channel
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read more
Pen-Like Tool Quickly and Non-Invasively Detects Opioids from Skin
Opioid drugs such as fentanyl, morphine, and oxycodone are the primary substances associated with overdose cases in the United States. Standard drug screening procedures typically involve collecting blood,... Read moreMolecular Diagnostics
view channel
New Blood Test for Leukemia Risk Detection Could Replace Bone Marrow Sampling
Myelodysplastic syndrome (MDS) is a condition typically associated with aging, where blood stem cells fail to develop into fully functional blood cells. Early and accurate diagnosis is vital, as MDS can... Read more
Blood Test Detects Preeclampsia Risk Months Before Symptoms Appear
Preeclampsia, a pregnancy-related complication characterized by elevated blood pressure and organ dysfunction, remains a major contributor to maternal and infant health issues globally. Existing screening... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreImmunology
view channel
Blood Test Detects Organ Rejection in Heart Transplant Patients
Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer
Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more
Computational Tool Exposes Hidden Cancer DNA Changes Influencing Treatment Resistance
Structural changes in tumor DNA are among the most damaging genetic alterations in cancer, yet they often go undetected, particularly when tissue samples are degraded or of low quality. These hidden genomic... Read morePathology
view channel
Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response
Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy
Labs that use traditional image analysis methods often suffer from bottlenecks and delays. By digitizing their pathology practices, labs can streamline their work, allowing them to take on larger caseloads... Read more
Saliva-Based Testing to Enable Early Detection of Cancer, Heart Disease or Parkinson’s
Saliva is one of the most accessible biological fluids, yet it remains underutilized in clinical practice. While saliva samples are used to perform genetic tests to determine, for example, paternity, the... Read moreTechnology
view channel
New POC Biosensing Technology Improves Detection of Molecular Biomarkers
Traditional diagnostic procedures in medicine typically involve sending a patient’s blood or tissue samples to clinical laboratories, where trained scientists perform testing and data interpretation.... Read more
Enhanced Lab Data Management and AI Critical to Labs of the Future, Finds Survey
Data plays a key role in the transformation of today’s digital laboratories, acting both as a key challenge and a catalyst for innovation, as revealed by a survey of over 150 scientists.... Read moreIndustry
view channel
AMP Releases Best Practice Recommendations to Guide Clinical Laboratories Offering HRD Testing
Homologous recombination deficiency (HRD) testing identifies tumors that are unable to effectively repair DNA damage through the homologous recombination repair pathway. This deficiency is often linked... Read more